Company intelligence / Profile preview

OralDNA Labs

Eden Prairie, Minnesota, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

OralDNA Labs commercializes multiple salivary diagnostic assays for oral bacteria, viruses, and genetic markers linked to oral/systemic disease; offers salivary collection, molecular assay, and gene risk marker profiling. Its COVID-19 PCR test received FDA EUA. Early results are broadly used in dental and medical practices for risk stratification and personalized care

Therapeutic areas: CardiovascularImmunologyInfectious DiseasesOtherOncology
Modalities: DeviceDiagnostic assayPCR-based assayNext-generation sequencing-based assay
Industry: Molecular Diagnostics

Partnerships

Development partnerships for point-of-care PCR platform (e.g., Sensible Diagnostics asset acquisition)no major biopharma partnerships disclosed

Beyond the preview

Go deeper on OralDNA Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OralDNA Labs.

Explore the full profile